Delivering clinical research to make patients, and the NHS, better Finance in CRN: North Thames: Research Capability Funding, the receipt and distribution.

Slides:



Advertisements
Similar presentations
NIHR Delivering Better Health Through Training Researchers 19 September 2011 Dr David Cox Deputy Director – Research Faculty.
Advertisements

NIHR Delivering Better Health 20 November 2012, Leeds Dr David Cox Deputy Director – Research Finance & Programmes.
Research Design Service West Midlands RfPB Research Funding Application Workshop 28 th February 2014.
Senior Manager – Research Finance & Programmes
1 Attributing the costs of health & social care Research & Development – Understanding AcoRD Trudi Simmons Senior Manager – Research Finance & Programmes.
Research and Development Department A Quick Guide to Using EDGE v2 for Researchers Version 1.2 – 23 February
Essentials of Fund 73 WASBO Accounting Seminar March, 2009 Presented by: Kathy Guralski, School Finance Auditor Wisconsin Department of Public Instruction.
Health and Wellbeing in the new NHS commissioning landscape 26 March 2012 Natasha Cooper Strategic Commissioning Development Manager.
Attributing the costs of health Research & Development – AcoRD Elizabeth Coote Head of Non-Commercial Research Services TASC NRS – delivering.
Welcome to the NIHR Peter Knight, Deputy Director Research Contracting, Information Intelligence and Stakeholder Engagement NIHR Trainees Meeting Leeds.
overview outcomes-focused investment priorities. investing over 3 years (2008 – 2011) and beyond. a fundamentally different approach to previous grant.
AcoRD Implementation Amber O’Malley, CRN Funding and Contracts Manager & AcoRD Business Lead.
CCG assurance & development
ROLE OF NURSES IN CLINICAL RESEARCH IN MALAWI OWEN DAIRE BSCN MPH RNM.
Grant Writing1 Grant Writing Lecture What are the major types of grants available in mental health research? What is the process of grant preparation and.
Lotterywest Grants Workshop (opportunities & demystifying the process)
Unit 4: Monitoring Data Quality For HIV Case Surveillance Systems #6-0-1.
Models for a cross agency rural Allied Health workforce Richard Cheney, Delys Brady, Graeme Kershaw, Linda Cutler, Jenny Preece.
Embedding Research in Practice Judy Lawrence RD PhD
Office of Special Education Fall Forum 2013 General Initiatives and the Role of Special Education.
Criteria for Centres of Expertise for Rare Diseases in the EU following EUCERD Recommendations RARECARENet Project: Consensus meeting on.
The Chief Scientist Office. Developments/Restructuring Of Research Funding In Scotland Overview of NHS Infrastructure funding ( ) What we have.
Care Act 2014 Anne Clarke Head of Adult Social Care Sue Alexander Head of Finance & Business Support 23 rd April 2015.
National Confidential Inquiry into Suicide and Homicide by People with Mental Illness National Learning Disability Review Function Options Appraisal Report.
NIHR Delivering Better Health 26 November 2013, Leeds Dr David Cox Deputy Director – Research Finance & Programmes.
NIHR CLAHRC for Northwest London Collaborations for Leadership in Applied Health Research and Care November 2008.
Delivering research to make patients, and the NHS, better Patient involvement in primary care research NAPP Annual Meeting, Leeds, 7 th June 2014, Leeds.
HRSA SURGE CAPACITY DATA SURVEY TECHNICAL ASSISTANCE California Department of Health Services Emergency Preparedness Office.
Mapping the Future A Vision for health and social care provision in Harrogate and Rural District.
The Role of the Research Office Joint Research & Enterprise Office (JREO) St George’s University of London and St George’s University Hospitals NHS Foundation.
12-Oct-15 NIHR Monitoring and Evaluation Evaluation of Research Impact: Options and Challenges October 2012.
Developing a National Critical Care Clinical Research Network: what’s in it for trainees? Paul Dark Associate Professor, Faculty of Medical and Human Sciences,
Grants to States to Support Oral Health Workforce Activities HRSA Pre-Review Conference Call April 14, 2015 U.S. Department of Health and Human.
Fellowships Day at Imperial College Sarah Fox 3 rd July 2007.
NIHR Research Design Service London Enabling Better Research Dr Caroline Burgess General Adviser 13 th November 2013.
Evaluation, Trials and Studies Coordinating Centre Developing Sight Loss and Vision research questions: a funder’s perspective Anna Tallant Scientific.
How To Design a Clinical Trial
Access to drugs, Reducing bottlenecks Matt Cooper Business Development & Marketing Director NIHR Clinical Research Network
NHS Education & Training Operating Model from April 2013 Liberating the NHS: Developing the Healthcare Workforce From Design to Delivery.
John McGeagh, PhD | NIHR CLAHRC West Collaboration for Leadership in Applied Health Research and Care The power and potential pitfalls of working with.
Pilot and Feasibility Studies NIHR Research Design Service Sam Norton, Liz Steed, Lauren Bell.
NIHR Themed Call Prevention and treatment of obesity Writing a good application and the role of the RDS 19 th January 2016.
Annual R&D Report Professor Graham Thornicroft. Achievements and Highlights 1 Specialist NIHR Biomedical Research Centre Technology Platform funding 6.
CONSTRAINTS TO PRIMARY HEALTH CARE DELIVERY THE GOVERNMENT OBJECTIVES FOR DELIVERING PHC SERVICES To increase accessibility to quality health care services.
Delivering research to make patients, and the NHS, better Introduction to the Research Ready Accreditation Kelly Adams, Cross Divisional Support Manager,
Syrian Refugee Resettlement Programme: Phase 2 overview Presented by: Adam Bell Date: 25 th February 2016.
AssessPlanDo Review QuestionYesNo? Do I know what I want to evaluate and why? Consider drivers and audience Do I already know the answer to my evaluation.
Research for Patient Benefit Preparing a research proposal What makes a good proposal? Professor Scott Weich, Panel Chair.
Postgraduate Medical Education and Training Tariffs Alex Glover Local Director Prof Namita Kumar Postgraduate Dean.
Public Health Research Programme Preventing the development and spread of Antimicrobial Resistance am - 2 October 2013 NIHR Public Health Research.
SECCN/SPACeR Critical Care Conference Introduction to the NIHR Research Design Service Research Design Service- South East Dr Bernadette Egan University.
Health Education England ‘People are the neglected area of reform’ Focus On Education Commissioning Chris Jeffries HEE Finance Transition lead.
Identification of eligible patients for clinical research within primary care (examples from Keele) Presented by Dr Martyn Lewis.
What is an Apprenticeship? Benefits, Issues and Challenges Emma Wilton Widening Participation Manager.
Impact of the Comprehensive Spending Review (Part 1) How the CSR will change the way providers work and deliver training Ainsley Cheetham Thursday 25 th.
Update – April 2015 Champions for Research Support Meeting Delivering research to make patients, and the NHS, better.
Private and confidential Community Pharmacy Future Four-or-more medicines support service Update on progress and next steps Approved18 th June 2012 This.
Evaluation Planning Checklist (1 of 2) Planning Checklist Planning is a crucial part of the evaluation process. The following checklist (based on the original.
PMS Contract review process June 2015.
Research and Development Dr Julie Hankin Medical Director.
Leicestershire, Northamptonshire and Rutland Comprehensive Local Research Network Improving the health and wealth of the nation through research: Local.
London (South) Comprehensive Local Research Network
How To Design a Clinical Trial
New Member Orientation June 9, 2017
Measuring CRN HLO 4 for 14/15 Delivering clinical research to
Help with developing research projects - Introducing the NIHR Research Design Service (RDS) Talked about ways into research and the next session looks.
Designing Research that Improves Health and Wellbeing for All How the NIHR Research Design Service North East can help.
An Introduction to the NIHR programmes
How to apply successfully to the NIHR HTA Board?
How to get support with clinical research studies
Presentation transcript:

Delivering clinical research to make patients, and the NHS, better Finance in CRN: North Thames: Research Capability Funding, the receipt and distribution of our Network allocation and the principles of AcoRD John Sheedy Head of Finance and Information Feb-2015

Introduction What is Research Capability Funding (RCF)? –How is it awarded? –How can it be used? –How much RCF did the North Thames region CCGs receive? North Thames receives the largest LCRN allocation of £30.6m –How is the LCRN allocation derived? –How do we allocate LCRN funding? What can Network funding be used for: the principles of AcoRD

Research Capability Funding: How is it awarded? Research Capability Funding (RCF) is awarded each year by the Department of Health in proportion to the total amount of NIHR income received by an organisation An organisation must have recruited 500 patients to NIHR non-commercial studies in the CRN reporting period: 1 st October to 30 th September each year If 500 patients are recruited, the minimum allocation of £20k will be received An amount of £75k is awarded for each designated NIHR Senior Investigator within an organisation An organisation may receive approximately 44p/£1 of NIHR grant income, 20p/£1 of NIHR BRC income and potentially other amounts for alternative NIHR streams e.g. NIHR Clinical Research Facilities

Research Capability Funding: How can it be used and how much did North Thames CCGs receive? Research Capability Funding (RCF) can be used flexibly to maintain research capacity and capability in an organisation or at an individual general practice level More specifically the funding can be used to pay the salary costs of individuals supporting or undertaking patient-based research RCF can also be used to meet the hosting costs of NIHR-funded research not already fully supported by an alternative funding stream In the North Thames region in 2015/16, four CCGs have received an allocation of £20k: NHS Camden, NHS City & Hackney, NHS Newham and NHS Tower Hamlets

Network Funding: How is the total LCRN allocation derived? The annual Network allocation is comprised of several components: –Activity-based funding (~73%) –Per capita (~15%) –Project-based activity (~6%) –Leadership management (~4%) –Performance premium (~2%)

Network Funding: How are the individual components derived? Activity-based funding –The value is calculated based on the recruitment, i.e. uploaded accruals, that occur in the 12-months between the 1 st of October and the 30 th of September –The recruitment is weighted with a ratio of 1:3:14 according to whether the study is a large sample size study, an observational study or an interventional study –North Thames received the 3rd highest recruitment-based allocation for 2015/16

Network Funding: The impact of the recruitment weighting

Network Funding: The per capita component The per capita is a population-based allocation North Thames has the 3 rd highest per capita allocation North Thames has 10% of the national population

Project-based funding The project-based funding allocation is also activity-based It is comprised of two elements: –Lead Network –Study-wide governance reviews (weighted) North Thames receives the largest project-based allocation of any Network

How much do we allocate to each budget category?

Network Funding: What can Network funding be used for and the principles of AcoRD AcoRD, which applies to all studies where funding was originally sought after the 1 st of October 2012, guides the cost attribution for all non-commercial studies in the NHS AcoRD replaced the previous guidance document entitled ARCO (2005) however ARCO can still apply when studies have originally been funded prior to the 1 st of October 2012 AcoRD focuses on the primary purpose of an activity to guide its attribution and makes a distinction between three types of cost: –Research (part A and part B) –Support –Treatment

Network Funding: What can Network funding be used for and the principles of AcoRD – Research costs A research cost activity is one that is primarily being carried out to complete the research study and answer the research question. Research activities are not directly related to the provision of patient care. Examples of research costs would be tests conducted to test the efficacy of an intervention, patient randomisation and data analysis needed to answer the research question The funding for research costs is provided by the grant funder(s) For studies wholly or part funded by AMRC-member charities, the research cost part B activities will be paid by alternative sources e.g. the CRN or Trust RCF An example of a part B activity is data collection, which would not be supported for studies without AMRC-member charity funding

Network Funding: What can Network funding be used for and the principles of AcoRD – NHS Support costs An NHS support activities are those additional patient care costs that would cease once the R&D activity ceased The taking of informed consent, which is an NHS support cost in almost all contexts, would not continue once the research study has ended A second example of an NHS support cost is the identification of eligible participants for a research study through the reviewing of medical records. This is not to be confused with screening to determine individual eligibility for a study according to the inclusion and exclusion criteria Other examples of support activities would be additional OP attendances or tests, which are only required for safety purposes The resource to deliver the NHS support activities is provided by the LCRN(s)

Network Funding: What can Network funding be used for and the principles of AcoRD – NHS Treatment costs An NHS Treatment activity is one that would continue after the end of the R&D activity. For the purposes of attribution, we must presume that the R&D activity would be adopted into practice Examples of treatment costs include: –The supply and administration of any medicine/device/therapy being studied irrespective of whether it is experimental –Supplying and administering any active comparators but not placebo or sham treatments –Investigations and tests that would continue to be provided after the R&D study has stopped The funding for NHS Treatment costs come from existing commissioning routes i.e. CCGs The funding for Excess treatment cost must also come from CCGs via local mechanisms, which we realise can be a challenging area

Summary RCF is used to maintain capacity in research-active NHS organisations We allocate the majority of our funding to support research delivery The LCRN are only able to provide resource to support NHS Support activities as governed by AcoRD: AcoRD: AcoRD Annex A: __List_of_Common_research_Activities_March_2013_for_publication.pdf AcoRD Annex B: